Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
1. BMY and Pfizer sell Eliquis directly, cutting prices over 40%. 2. New pricing aims to reduce patient out-of-pocket costs significantly. 3. Eliquis still costs more than Medicare negotiated prices set for next year. 4. Effort targets uninsured and self-pay patients, bypassing traditional middlemen. 5. Analyst predicts no major pricing headwinds for BMY from this initiative.